Sun Pharma receives USFDA approval for cancer drug

05 May 2011 Evaluate

Sun Pharmaceutical Industries has received US health regulator’s approval for generic docetaxel injection, used in treating cancer, in the American market. The company’s subsidiary - Sun Pharma Advanced Research Company - has received abbreviated new drug approval from US Food and Drug Administration for Docefrez in strength of 20 mg/vial and 80 mg/vial. The company’s product is indicated for metastatic breast cancer, lung cancer and hormone refractory metastatic prostate cancer. This product could potentially give the company over $50 million over a year.

crackcrack

Sun Pharma Inds. Share Price

1804.95 -13.65 (-0.75%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×